Astrazeneca Pharma India Ltd
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|
| Revenue | 584.56 | 618.18 | 565.26 |
| Operating Expense | 518.78 | 566.74 | 489.20 |
| Net Profit | 44.88 | 32.59 | 54.22 |
| Net Profit Margin | 7.68% | 5.27% | 9.59% |
| Earning Per Share | 17.95 | 13.04 | 21.69 |
| EBIDTA | 66.83 | 41.49 | 76.47 |
| Effective Tax Rate | 21.75% | 7.78% | 24.99% |
Particulars
Mar 2026
Revenue584.56
Operating Expense518.78
Net Profit44.88
Net Profit Margin7.68
Earning Per Share17.95
EBIDTA66.83
Effective Tax Rate21.75
